Results for tag: "Colorectal Cancer Test"

The Colorectal Cancer Test market within the In Vitro Diagnostics (IVD) industry is a rapidly growing segment. It is driven by the increasing prevalence of colorectal cancer, the need for early detection, and the availability of advanced testing technologies. Tests such as fecal immunochemical tests (FITs) and stool DNA tests (sDNA) are used to detect colorectal cancer in its early stages. These tests are non-invasive, cost-effective, and provide accurate results. Additionally, the increasing awareness of colorectal cancer and the availability of government-funded screening programs are expected to drive the market growth. Some of the key players in the Colorectal Cancer Test market include Abbott Laboratories, Becton Dickinson and Company, Cepheid, Hologic, Inc., Qiagen, Roche Diagnostics, Siemens Healthineers, and Sysmex Corporation. Show Less Read more